These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2907712)

  • 21. Direct and synergistic interactions of 3,5,3'-triiodothyronine and the adrenergic system in stimulating sugar transport by rat thymocytes.
    Segal J; Ingbar SH
    J Clin Invest; 1980 May; 65(5):958-66. PubMed ID: 7364946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the antiarrhythmic activity of one N-substituted piperazine derivative of trans-2-amino-3-hydroxy-1, 2, 3, 4-tetrahydroanaphthalene.
    Staneva-Stoycheva D; Boyadjiev T; Raynova L; Mihaylova S; Tomov T
    Acta Physiol Pharmacol Bulg; 1979; 5(3):51-8. PubMed ID: 44072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of adrenergic control of glucagon secretion from isolated perfused rat pancreas.
    Filipponi P; Marcelli M; Nicoletti I; Pacifici R; Santeusanio F; Brunetti P
    Diabete Metab; 1982 Dec; 8(4):313-8. PubMed ID: 7160520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol.
    Hayes JS; Pollock GD; Fuller RW
    J Pharmacol Exp Ther; 1984 Dec; 231(3):633-9. PubMed ID: 6094797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-1 adrenergic stimulation of glucose uptake in rat white adipocytes.
    Faintrenie G; Géloën A
    J Pharmacol Exp Ther; 1998 Aug; 286(2):607-10. PubMed ID: 9694910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of beta-adrenoceptors in a central regulation of the ovarian progesterone release in rats.
    De Bortoli MA; Garraza MH; Aguado LI
    Neuro Endocrinol Lett; 2002 Feb; 23(1):27-31. PubMed ID: 11880859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of VLDL associated triacylglycerol secretion by both alpha- and beta-adrenoceptor agonists in isolated rat hepatocytes.
    Rasouli M; Zahraie M
    Eur J Pharmacol; 2006 Sep; 545(2-3):109-14. PubMed ID: 16876783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic and endocrine effects of circulating catecholamines in fetal sheep.
    Jones CT; Ritchie JW
    J Physiol; 1978 Dec; 285():395-408. PubMed ID: 217988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modified metabolic effects of adrenaline in cold-acclimation (author's transl)].
    Yahata T; Kurahashi M; Ohno T; Kuroshima A
    Hokkaido Igaku Zasshi; 1977 Jul; 52(4):343-52. PubMed ID: 21839
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of (-)-(R)-1-(p-hydroxyphenyl)-2-[3,4-dimethoxyphenethyl)amino]ethanol (TA-064), a new cardiotonic agent, on circulating parameters of carbohydrate and lipid metabolism in the rat.
    Inamasu M; Totsuka T; Morita T; Takeyama S
    Biochem Pharmacol; 1984 Jul; 33(14):2171-7. PubMed ID: 6147139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenergic receptor mechanisms involved in the hyperglycemia and hyperlactic-acidemia produced by sympathomimetic amines in the cat.
    Kuo SH; Kamaka JK; Lum BK
    J Pharmacol Exp Ther; 1977 Aug; 202(2):301-9. PubMed ID: 18597
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of fibrinogen degradation products (FDP) on heart rate and some metabolic parameters in the rat.
    Buczko W
    Acta Physiol Pol; 1978; 29(3):259-66. PubMed ID: 707144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanism of the pyrazidol potentiation of the hyperglycemic effect of adrenaline].
    Egorova EF; Liberman SS
    Farmakol Toksikol; 1978; 41(1):36-40. PubMed ID: 624387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neurophoarmacologic profile of an aminotetraline derivative].
    Raĭnova L; Micheva M; Kharalambieva M; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1977; 16(4):211-6. PubMed ID: 590178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in plasma glucose, lactate and free fatty acids in lambs during summit metabolism and treatment with catecholamines.
    Alexander G; Mills SC; Scott TW
    J Physiol; 1968 Sep; 198(2):277-89. PubMed ID: 5698274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic responses to a new beta-adrenoceptor agonist, ICI 118,587, in conscious rats.
    Ichihara K; Abiko Y; Miura I; Nishimura T
    Pharmacology; 1983; 27(4):202-10. PubMed ID: 6138784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin suppressive effects of aminotetralin analogs and of dopamine.
    Blum JW
    Eur J Pharmacol; 1984 Oct; 105(3-4):239-44. PubMed ID: 6391938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of metabolic effect of ammonia and adrenaline infusions in sheep.
    Garwacki S; Wiechetek M; Barej W
    Q J Exp Physiol Cogn Med Sci; 1979 Jan; 64(1):23-9. PubMed ID: 256166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.